News|Articles|February 1, 2003
New Ways to Recruit Trial Subjects
Author(s)Faiz Kermani, Ph.D
Pietro Bonacossa
Pietro Bonacossa
To minimize time to market, sponsors must explore new subject recruitment techniques.
Advertisement
Clinical trials are a vital step toward bringing new drugs to market. U.S.-based clinical trial activities increased by 6% in 2001, the largest rise since 1990.1 But although pharmaceutical companies pay close attention to the science when designing their clinical trials, few consider how they will get enough subjects to participate. As a result, most trials are plagued by delays that can cost pharmaceutical companies millions of missed sales. Delays in getting a drug to market are estimated to cost companies around $1 million a day.2
Articles in this issue
over 22 years ago
Clinical Trials in Indiaover 22 years ago
Using Mock Inspections to Prepare for FDA GCP Inspectionsover 22 years ago
Tweaking the EU Rules on Clinical Trialsover 22 years ago
AIDS Campaign Spotlights Global Clinical Researchover 22 years ago
The Woodsman?s Taleover 22 years ago
New Ways to Recruit Trial Subjectsover 22 years ago
A 6-Month Process for Planning Multinational Clinical TrialsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How AI Can Help Physicians Identify Eligible Trials Faster
September 5th 2025
Advertisement
Advertisement